MacroGenics, Inc. - ROE
MGNX
Price:
$4.13
Market Cap:
$262.52M
MacroGenics, Inc. is a U.S.-based biopharmaceutical company specializing in the development and commercialization of antibody-derived treatments primarily aimed at combating cancer. The company's sole approved product is MARGENZA (margetuximab-cmkb). This drug acts as an antagonist to the human epidermal growth factor receptor 2 (HER2) and is prescribed in conjunction with chemotherapy for adult patients suffering from metastatic HER2-positive breast cancer who have previously undergone at least two different anti-HER2 treatment regimens. Beyond its commercialized medicine, MacroGenics boasts an extensive pipeline of investigational immuno-oncology therapies. These include: MGC018, an antibo...[Read more]
Industry
Biotechnology
IPO Date
2013-10-10
Stock Exchange
NASDAQ
Ticker
MGNX
PE Ratio
[-3.72]
ROE
[-147.80%]
Current Ratio
[1.90]
Dividend Yield
[0%]
Enterprise Value
[232.51M]
Dividend History
The ROE as of June 2026 (TTM) for MacroGenics, Inc. (MGNX) is -147.80%
According to MacroGenics, Inc.’s latest financial reports and current stock price. The company's current ROE is -147.80%. This represents a change of 134.99% compared to the average of -62.90% of the last 4 quarters.
MacroGenics, Inc. (MGNX) Historical ROE (quarterly & annually)
How has MGNX ROE performed in the past?
The mean historical ROE of MacroGenics, Inc. over the last ten years is -57.51%. The current -147.80% ROE has changed 156.99% with respect to the historical average. Over the past ten years (40 quarters), MGNX's ROE was at its highest in in the September 2024 quarter at 46.90%. The ROE was at its lowest in in the March 2026 quarter at -173.48%.
Average
-57.51%
Median
-61.76%
Minimum
-134.23%
Maximum
-5.94%
MacroGenics, Inc. (MGNX) ROE by Quarter and Year
Discovering the peaks and valleys of MacroGenics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 976.33%
Maximum Annual ROE = -5.94%
Minimum Annual Increase = -92.96%
Minimum Annual ROE = -134.23%
| Year | ROE | Change |
|---|---|---|
| 2025 | -134.23% | 132.63% |
| 2024 | -57.70% | 872.17% |
| 2023 | -5.94% | -92.96% |
| 2022 | -84.33% | -0.02% |
| 2021 | -84.35% | 92.37% |
| 2020 | -43.85% | -33.39% |
| 2019 | -65.83% | -6.75% |
| 2018 | -70.59% | 976.33% |
| 2017 | -6.56% | -69.88% |
| 2016 | -21.78% | 238.82% |
MacroGenics, Inc. (MGNX) Average ROE
How has MGNX ROE performed in the past?
The current ROE of MacroGenics, Inc. (MGNX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-65.96%
5-year avg
-73.31%
10-year avg
-57.51%
MacroGenics, Inc. (MGNX) ROE vs. Peers
How is MGNX’s ROE compared to its peers?
MacroGenics, Inc.’s ROE is greater than Ovid Therapeutics Inc. (-22.51%), greater than Context Therapeutics Inc. (-59.95%), less than Clene Inc. (233.93%), greater than Whitehawk Therapeutics Inc (-79.63%), greater than Shattuck Labs, Inc. (-60.73%), greater than Connect Biopharma Holdings Limited (-49.43%), less than Oramed Pharmaceuticals Inc. (55.29%), greater than Zentalis Pharmaceuticals, Inc. (-53.61%), greater than Coya Therapeutics, Inc. (-57.26%), greater than InflaRx N.V. (-94.90%),
| Company | ROE | Market cap |
|---|---|---|
| -22.51% | $299.38M | |
| -59.95% | $58.06M | |
| 233.93% | $61.95M | |
| -79.63% | $218.58M | |
| -60.73% | $237.12M | |
| -49.43% | $125.93M | |
| 55.29% | $158.79M | |
| -53.61% | $263.39M | |
| -57.26% | $89.59M | |
| -94.90% | $130.74M |
Build a custom stock screener for MacroGenics, Inc. (MGNX) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MacroGenics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
MacroGenics, Inc. (MGNX) and other stocks custom spreadsheet templates
The easiest way to analyze a company like MacroGenics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is MacroGenics, Inc.'s ROE?
How is the ROE calculated for MacroGenics, Inc. (MGNX)?
What is the highest ROE for MacroGenics, Inc. (MGNX)?
What is the 3-year average ROE for MacroGenics, Inc. (MGNX)?
What is the 5-year average ROE for MacroGenics, Inc. (MGNX)?
How does the current ROE for MacroGenics, Inc. (MGNX) compare to its historical average?